Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

476 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Autologous hematopoietic stem cell transplantation for intravascular large B-cell lymphoma: the European Society for Blood and Marrow Transplantation experience.
Meissner J, Finel H, Dietrich S, Boumendil A, Kanfer E, Laboure G, Abecasis M, Cornelissen J, Delage J, Finke J, Hess U, Ludwig H, Mohty M, Pabst T, Pioltelli P, Robinson S, Samaras P, Montoto S, Dreger P. Meissner J, et al. Among authors: dreger p. Bone Marrow Transplant. 2017 Apr;52(4):650-652. doi: 10.1038/bmt.2016.339. Epub 2016 Dec 19. Bone Marrow Transplant. 2017. PMID: 27991887 Clinical Trial. No abstract available.
Results of a randomised, controlled, multicentre study of recombinant human granulocyte colony-stimulating factor (filgrastim) in patients with Hodgkin's disease and non-Hodgkin's lymphoma undergoing autologous bone marrow transplantation.
Schmitz N, Dreger P, Zander AR, Ehninger G, Wandt H, Fauser AA, Kolb HJ, Zumsprekel A, Martin A, Hecht T. Schmitz N, et al. Among authors: dreger p. Bone Marrow Transplant. 1995 Feb;15(2):261-6. Bone Marrow Transplant. 1995. PMID: 7539668 Clinical Trial.
Autografting of highly purified peripheral blood progenitor cells following myeloablative therapy in patients with lymphoma: a prospective study of the long-term effects on tumor eradication, reconstitution of hematopoiesis and immune recovery.
Dreger P, Viehmann K, von Neuhoff N, Glaubitz T, Petzoldt O, Glass B, Uharek L, Rautenberg P, Suttorp M, Mills B, Mitsky P, Schmitz N. Dreger P, et al. Bone Marrow Transplant. 1999 Jul;24(2):153-61. doi: 10.1038/sj.bmt.1701862. Bone Marrow Transplant. 1999. PMID: 10455343
Treatment-related mortality and graft-versus-leukemia activity after allogeneic stem cell transplantation for chronic lymphocytic leukemia using intensity-reduced conditioning.
Dreger P, Brand R, Hansz J, Milligan D, Corradini P, Finke J, Deliliers GL, Martino R, Russell N, Van Biezen A, Michallet M, Niederwieser D; Chronic Leukemia Working Party of the EBMT. Dreger P, et al. Leukemia. 2003 May;17(5):841-8. doi: 10.1038/sj.leu.2402905. Leukemia. 2003. PMID: 12750695 Review.
Enhanced antileukemic activity of allogeneic peripheral blood progenitor cell transplants following donor treatment with the combination of granulocyte colony-stimulating factor (G-CSF) and stem cell factor (SCF) in a murine transplantation model.
Hartung G, Zeis M, Glass B, Dreger P, Steinmann J, Schmitz N, Uharek L. Hartung G, et al. Among authors: dreger p. Bone Marrow Transplant. 2003 Jul;32(1):49-56. doi: 10.1038/sj.bmt.1704072. Bone Marrow Transplant. 2003. PMID: 12815478
476 results